NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

Clinical trial NCT05197322 · RECRUITING

Trial details

NCT number: NCT05197322
Sponsor: University College, London
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Colon

Start date: 2022-07-20
Primary completion: 2026-07-31
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.